Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Moorhouse

- PMLiVE

Takeda rebels take aim at Shire acquisition

Shareholder group concerned about $30bn debt burden

Choices, choices…

Not all innovative business models are equal

- PMLiVE

Building the Future

Transforming your business model is difficult, but doable - here’s how

- PMLiVE

Choosing destiny

As our market transforms, firms must choose their new business model carefully

- PMLiVE

Explosive evolution

Companies are being forced to diversify and specialise their business models

- PMLiVE

OPEN Health acquires Choice Healthcare Solutions

Will rebrand the agency under its Succinct agency offering

Healthcare business and operating models redefined

How critical healthcare needs can be met more efficiently and effectively

Deal Watch March 2016

AstraZeneca, Roche, Sanofi and Valeant are featured in this month’s roundup of pharma deals

Sanofi reception

Sanofi hints at sweetened Medivation deal – or hostile bid

CEO Oliver Brandicourt claims “overwhelming support” for deal from shareholders

- PMLiVE

IMS Health to merge with Quintiles

Will create pharma services firm worth almost $18bn

Sanofi reception

Medivation unimpressed with Sanofi’s offer

CEO says the offer “substantially undervalues” the oncology specialist

- PMLiVE

AbbVie adds to cancer portfolio with $9.8bn Stemcentrx deal

Continues to build its oncology business to lessen its reliance on Humira

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links